Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009
Open Access
- 20 August 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 65 (10), 2116-2118
- https://doi.org/10.1093/jac/dkq279
Abstract
Resistance to azole antifungal drugs in Aspergillus fumigatus is now a major clinical problem in some locations. Here we update our previous experience with data from 2008–09. We tested all A. fumigatus isolates submitted to the Mycology Reference Centre Manchester in 2008 and 2009 for susceptibility to itraconazole, voriconazole and posaconazole. We undertook CYP51A sequencing for most of the azole-resistant isolates. Of 230 isolates, 64 (28%) were azole resistant. In 2008 and 2009, 14% and 20% of patients had resistant isolates, respectively. During this period 62 of 64 (97%) were itraconazole resistant, 2 of 64 (3%) were only voriconazole resistant and 78% of cases were multi-azole resistant. Forty-three percent of isolates did not carry a cyp51A mutation (previously the most common azole resistance mechanism), indicating that other mechanisms must be responsible and are increasing in frequency. Azole resistance is evolving and growing in frequency. Established and novel mechanisms may be responsible.Keywords
This publication has 10 references indexed in Scilit:
- Acquired resistance to voriconazole and itraconazole in a patient with pulmonary aspergillomaMedical Mycology, 2010
- Azole-resistance in Aspergillus: Proposed nomenclature and breakpointsDrug Resistance Updates, 2009
- Wild-Type MIC Distribution and Epidemiological Cutoff Values for Aspergillus fumigatus and Three Triazoles as Determined by the Clinical and Laboratory Standards Institute Broth Microdilution MethodsJournal of Clinical Microbiology, 2009
- Frequency and Evolution of Azole Resistance inAspergillus fumigatusAssociated with Treatment Failure1Emerging Infectious Diseases, 2009
- Emergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance MechanismPLoS Medicine, 2008
- Epidemiological Cutoffs and Cross-Resistance to Azole Drugs in Aspergillus fumigatusAntimicrobial Agents and Chemotherapy, 2008
- A New Aspergillus fumigatus Resistance Mechanism Conferring In Vitro Cross-Resistance to Azole Antifungals Involves a Combination of cyp51A AlterationsAntimicrobial Agents and Chemotherapy, 2007
- Multi-azole resistance in Aspergillus fumigatusInternational Journal of Antimicrobial Agents, 2006
- Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolateFungal Genetics and Biology, 2002
- Antifungal Drug Resistance in AspergillusJournal of Infection, 2000